Affordable Access

Publisher Website

ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells

Authors
Journal
Experimental Cell Research
0014-4827
Publisher
Elsevier
Volume
324
Issue
2
Identifiers
DOI: 10.1016/j.yexcr.2014.04.004
Keywords
  • Ankhd1
  • Yap1
  • Mask
  • Hippo Pathway
  • Prostate Cancer
  • Cell Cycle
Disciplines
  • Biology

Abstract

Abstract ANKHD1 is a multiple ankyrin repeat containing protein, recently identified as a novel member of the Hippo signaling pathway. The present study aimed to investigate the role of ANKHD1 in DU145 and LNCaP prostate cancer cells. ANKHD1 and YAP1 were found to be highly expressed in prostate cancer cells, and ANKHD1 silencing decreased cell growth, delayed cell cycle progression at the S phase, and reduced tumor xenograft growth. Moreover, ANKHD1 knockdown downregulated YAP1 expression and activation, and reduced the expression of CCNA2, a YAP1 target gene. These findings indicate that ANKHD1 is a positive regulator of YAP1 and promotes cell growth and cell cycle progression through Cyclin A upregulation.

There are no comments yet on this publication. Be the first to share your thoughts.